Skip to main content

Table 2 Frequencies of expression of the BCR-ABL rearrangements in patients with CML from different studies

From: Chronic myeloid leukemia: cytogenetics and molecular biology’s part in the comprehension and management of the pathology and treatment evolution

Types of BCR-ABL fusion transcripts

[50] Mexico N = 250

[51] Iran N = 75

[52] Sudan N = 112

[53] Nigeria N = 42

[54] Indonesia N = 183

b3a2 (e14a2)

35%

63%

5.5%

67.3%

74.3%

b2a2 (e13a2)

48%

20%

19.3%

21.4%

22.4%

b3a2/b2a2

7%

7.3%

1%

e1a2

1%

  1. (N): Number of patients included in the study; (%): Frequency of the variant